summary
Introduced
02/02/2021
02/02/2021
In Committee
02/02/2021
02/02/2021
Crossed Over
03/08/2021
03/08/2021
Passed
04/20/2021
04/20/2021
Dead
Signed/Enacted/Adopted
04/23/2021
04/23/2021
Introduced Session
117th Congress
Bill Summary
An Act To educate health care providers and the public on biosimilar biological products, and for other purposes.
AI Summary
This bill, the Advancing Education on Biosimilars Act of 2021, aims to educate healthcare providers, patients, and caregivers about biological products, including biosimilar and interchangeable biosimilar products. It allows the Secretary of Health and Human Services to maintain a website providing educational materials on key terms, regulatory standards, adverse event reporting, and the relationship between biosimilar and reference biological products. The bill also directs the Secretary to advance education and awareness among healthcare providers about the prescribing and clinical considerations for these products.
Committee Categories
Health and Social Services
Sponsors (2)
Last Action
Became Public Law No: 117-8. (on 04/23/2021)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
Loading...